Mineralocorticoid-receptor blockade, hypertension and heart failure.
Funder
John W
JW
Monash University, Australia. john.funder@phimr.monash.edu.au
D000450:Aldosterone / Q000097:blood; D002986:Clinical Trials as Topic; D000077545:Eplerenone; D006333:Heart Failure / Q000188:drug therapy*; D006727:Hormone Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D006973:Hypertension / Q000188:drug therapy*; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone / Q000031:analogs & derivatives / Q000627:therapeutic use
D006727:Hormone Antagonists; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000450:Aldosterone; D000077545:Eplerenone